RIFERIMENTI BIBLIOGRAFICI
Adachi A., Gendelman H.E., Koeing S. et al. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol., 59: 284-291.
Appay V. and Rowland-Jones S.L. (2002). Premature ageing of the immune system: the cause of AIDS?. Trends Immunol., 23: 580-585.
Arnold C. and Hodgson I.J. (1991). Vectorette PCR: a novel approach to genomic walking. Methods Appl., 1: 39-42.
Avrameas A., Strosberg A.D., Moraillon A., Sonigo P., Pancino G. (1993). Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins. Res. Virol., 144: 209-218.
Bachmann M.H., Sodora D.L., Matthiason-Dubard M., Learn G.H., Rodrigo A.G., Mazzetti P., Hoover E.A., Mullins J.I. (1997). Genetic diversity of feline immunodeficiency virus: dual infection, recombination and distinct evolutionary rates between envelope sequence clades. J. Virol., 71: 4241-4253.
Baldinotti F., Matteucci D., Mazzetti P., Giannelli C., Bandecchi P., Tozzini F., Bendinelli M. (1994). Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol., 68: 4572-4579.
Bandecchi P., Matteucci D., Baldinotti F., Guidi G., Abramo F., Tozzini F., Bendinelli M. (1992). Prevalence of feline immunodeficiency virus and other retroviral infections in sick cats in Italy. Vet. Immunol. Immunopathol., 31: 337-345.
Beatty J.A., Willett B.J., Gault E.A., Jarrett O. (1996). A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J. Virol., 70: 6199-6206.
Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., Tozzini F. (1995). Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev., 1: 87-122.
Bendinelli M., Pistello M., Del Mauro D., Cammarota G., Maggi F., Leonildi A., Giannecchini S., Bergamini C., Matteucci D. (2001). During readaptation in vivo,
a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistence at different times in individual hosts but through changes at the same position of the surface glycoprotein. J. Virol., 75: 4584-4593.
Bignall J. (1994). Human infection with SIV. Lancet, 343: 229.
Brown W.C., Bissey L., Logan K.S., Pedersen N.C., Elder J.H., Collison E.W. (1991). Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes. J. Virol., 65: 3359-3364.
Brunner D. and Pedersen N.C. (1989). Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J. Virol., 63: 5483-5488.
Burton D.R., Pyati J., Koduri R., Sharp S.J., ThorntonG.B., Parren P.W.H.I., Sawyer L.S.W., Hendry R.M., Dunlop N., Nara P.L et al. (1994). Efficient neutralization of primaryisolates of HIV-1 by a recombinant human monoclonal antibody. Science, 264: 1024-1027.
Burton D.R., Saphire E.O., Parren P.W. (2001). A model for neutralization of viruses based on antibody coating of the virion surface. Curr. Top Microbiol. Immunol., 260: 109-143.
Cammarota G., Da Prato L., Nicoletti E., Matteucci D., Bendinelli M., Pistello M. (1996). Quantitation of feline immunodeficiency proviruses in doubly infected cats using competitive PCR and a fluorescence-based RFLP. J. Virol. Methods, 62: 21-31.
Caputo A., Betti M., Boarini C., Mantovani I., Corallini A., Barbanti-Brodano G. (1999). Multiple functions of human immunodeficiency virus type 1 Tat protein in the pathogenesis of AIDS. Recent Res. Devel. Virol., 1: 753-771.
Carpenter M.A., Brown E.W., MacDonald D.W., O’Brien S.J. (1998). Phylogeographic patterns of feline immunodeficiency virus genetic diversity in the domestic cat. Virology, 251: 234-243.
Chiu and Greene (2006). Multifaceted antiviral actions of APOBEC3 cytidine deaminases. Trends in Immunology, 27: 291-297.
Coffin J. (1995). HIV population dynamics in vivo: implication for genetic variation, pathogenesis and therapy. Science, 267: 483-489.
Conticello S.G., Harris R.S., Neuberger M.S. (2003). The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol., 13: 2009-2013.
Dean G.A., Himathongkham S., Sparger E.E. (1999). Differential cell tropism of feline immunodeficiency virus molecular clones in vivo. J. Virol., 73: 2596-2603.
de Parseval A., Elder J.H. (1999). Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J. Virol., 73: 608-617.
de Parseval A., Chatterji U., Morris G., Sun P., Olson A.J., Elder J.H. (2004). Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. USA, 101: 13044-13049.
de Rozières S., Mathiason C.K., Rolston M.R., Chatterij U., Hoover E.A., Elder J.H. (2004). Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J. Virol., 78: 8971-8982.
Diehl L.J., Mathiason-Dubard C.K., O’Neil L.L., Obert L.A., Hoover E.A. (1995). Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J. Virol., 69: 6149-6157.
Dow S.W., Poss M.L., Hoover E.A. (1990). Feline immunodeficiency virus: a neurotropic lentivirus. J. Acquir. Immune Defic. Syndr., 3: 658-668.
Dow S.W., Dreitz M.J., Hoover E.A. (1992). Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells. Vet. Immunol. Immunopathol., 35: 23-35.
Dua N., Reubel G., Higgins J., Moore P.F., Pedersen N.C. (1994). An experimental study of primary feline immunodeficiency virus infection in cats and a historical comparison to acute simian and human immunodeficiency virus diseases. Vet. Immunol., Immunopathol., 43: 337-355.
Egberink H.F., Ederveen J., Montelaro R.C., Pedersen N.C., Horzinek M.C., Koolen M.J. (1990). Intracellular proteins of feline immunodeficiency virus and their antigenic relationship with equine infectious anaemia virus proteins. J. Gen. Virol., 71: 739-743.
Flynn J.N., Keating P., Hosie M.J., Mackett M., Stephens E.B., Beatty J.A., Neil J.C., Jarrett O. (1996). Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J. Immunol., 157: 3658-3665.
Franca R., Spadari S., Maga G. (2006). APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism. Med. Sci. Monit, 12: 92-98.
Gao F., Robertson D.L., Carruthers C.D., Morrison S.G., Jian B., Chen Y., Barrè-Sinoussi F., Girard M., Srinivasan A., Abimiku A.G., Shaw G.M., Sharp P.M.,
Hahn B.H. (1998). A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J. Virol., 72: 5680-5698.
Gemeniano M.C., Sawai E.T., Sparger E.E. (2004). Feline immunodeficiency virus ORF-A localizes to the nucleus and induces cell cycle arrest. Virology, 325: 167-174.
Giannecchini S., Matteucci D., Ferrari A. Pistello M., Bendinelli M. (2001). Feline immunodeficiency virus-infected cat sera associated with the development ofbroad neutralization resistance in vivo drive similar reversione in vitro. J. Virol., 75: 8868-8873.
Grisson R.D., Chenine A.L., Yeh L.Y., He J., Wood C., Bhat G.J., Xu W., Kankasa C., Ruprecht R.M. (2004). Infectious molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination. J. Virol., 78: 14066-14069.
Harbour D.A. (1992). Feline immunodeficiency virus infection as a model for HIV infection in man. Rev. Med. Virol., 2: 43-49.
Harris R.S. and Liddament M.T. (2004). Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol., 4: 868-877.
Heyndrickx L., Janssens W., Zekeng L., Musonda R., Anagonous S., van der Auwera G., Coppens S., Vereecken K., de Witte K. et al. (2000). Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by Gag/Env heteroduplex mobility assay. J. Virol., 74: 363-370.
Hosie M.J. and Jarrett O. (1990). Serological responses of cats to feline immunodeficiency virus. AIDS, 4: 215-220.
Inoshima Y., Kohmoto M., Ikeda Y., Yamada H., Kawaguchi Y., Tomonaga K., Miyazawa T., Kai C., Umemura T., Mikami T. (1996). Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats. J. Virol., 70 : 8518-8526.
Ikeda Y., Inoshima Y., Kawaguchi Y., Maeda K., Kohmoto M., Kai C., Miyazawa T., Mikami T. (1998). Protein-binding properties of the putative AP-1 and ATF sequences in the feline immunodeficiency virus long terminal repeat. J. Gen. Virol., 79 : 95-99.
Ishida T., Washizu T., Toriyabe K., Motoyoshi S., Tomoda I., Pedersen N.C. (1989). Feline immunodeficiency virus infection in cats of Japan. J. Am. Vet. Med. Assoc., 194: 221-225.
Jordan H.L., Howard J., Sellon R.K., Wildt D.E., Tompkins W.A., Kennedy-Stoskopf S. (1996). Transmission of feline immunodeficiency virus in domestic cats via artificial insemination. J. Virol., 70: 8224-8228.
Ishida T. and Tomoda I. (1990). Clinical staging of feline immunodeficiency virus infection. Nippon Juigaku Zasshi., 52: 645-864.
Kakinuma S., Motokava K., Hohdatsu T., Koyama H., Hashimoto H. (1995). Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtype. J. Virol., 69: 3639-3646.
Khabbaz RF., Heneine W., George JR., Parekh B., Rowe T., Woods T., Switzer WM., McClure HM., Murphey-Corb M., Folks TM. (1994). Brief report: infection of a laboratory worker with simian immunodeficiency virus. N. Engl. J. Med., 330: 172-177.
Kiyomasu T., Miyazawa T., Furuya T., Shibata R., Sakai H., Sakuragi J., Fukazawa M., Maki N., Hasegawa A., Mikami T., Adachi A. (1991). Identification of the feline immunodeficiency virus rev gene activity. J. Virol., 65: 4539-4542.
Ko W.Y., Ryan M.D., Akashi H. (2003). Molecular Phylogeny of the Drosophila melanogaster species subgroup. J. Mol. Evol., 57: 562-573.
Kuiken C., Thakallpalli R., Eskild A., de Ronde A. (1999 ). Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus. Am. J. Epidemiol., 152: 814-822.
Kusagawa S., Takebe Y., Yang R., Motomura K., Ampofo W., Brandful J., Koyanagi Y., Yamamoto N., Sata T., Ishikawa K., Nagai Y., Tatsumi M. (2001). Isolation and characterization of a full-length molecular DNA clone of Ghanaian HIV type 1 intersubtype A/G recombinant CRF02_AG, which is replication competent in a restricted host range. AIDS Res. Hum. Retrovir., 17: 649-655.
Lecossier D., Bouchonnet F., Clavel F., Hance A.J. (2003). Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science, 300: 1112.
Lockridge K.M., Himathongkham S., Sawai E.T., Chienand M., Sparger E.E. (1999). The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages. Virology, 261: 25-30.
Lombardi S., Garzelli C., La Rosa C., Zaccaro L., Specter S., Malvaldi G., Tozzini F., Esposito F., Bendinelli M. (1993). Identification of a linear neutralization site within the third variable region of feline immunodeficiency virus envelope. J. Virol., 67: 4742-4749.
Malik R., Kendall K., Cridland J., Coulston S., Stuart A.J., Snow D., Love D.N. (1997). Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney. Aust. Vet. J., 75: 323-327.
Maki N., Miyazawa T., Fukasawa M., Hasegawa A., Hayami M., Miki K., Mikami T. (1992). Molecular characterization and heterogeneity of feline immunodeficiency virus isolates. Arch. Virol., 123: 29-45.
Mansky L.M. (1998). Retrovirus mutation rates and their role in genetic variation. J. Gen. Virol., 79: 1337-1345.
Masharsky A.E. (2003). Molecular cloning and analysis of full-length genome of HIV type 1 strains prevalent in countries of the former soviet union. AIDS Res. Hum. Retrovir., 19: 933-939.
Matteucci D., Pistello M., Mazzetti P., Giannecchini S., Isola P., Merico A., Zaccaro L., Rizzuti A., Bendinelli M. (2000). AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus. Vaccine, 18: 119-130.
McCutchan F.E., Carr J.K., Bajani M., Sanders-Buell E., Harry T.O., Stoeckli T.C., Robbins K.E., Gashau W., Nasidi A., Janssens W., Kalish M.L. (1999). Subtype Gand multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology, 254: 226-234.
McCutchan F.E. (2000). Understanding the genetic diversity of HIV-1. AIDS, 14 (suppl.3): S31-S44.
McMichael A.J. and Phillips R.E. (1997). Escape of human immunodeficiency virus from immune control. Ann. Rev. Immunol., 15: 271-296.
Miyazawa T., Fukasawa M., Hasegawa A., Maki N., Ikuda K., Takahashi E., Hayami M., Mikami T. (1991). Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate. J. Virol., 65: 1572-1577.
Moore J.P. and Ho D.D. (1995). HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS, 9 (supp.A): S117-S136.
Morikawa S., Lutz H., Aubert A., Bishop D.H. (1991). Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland. Virus Res., 21: 53-63.
Mukai T., Kurosu T., Kinomoto M., Komoto S., Shiraga M., Auwanit W., Ikuta K. (2002). Construction and in vitro characterization of a molecularly cloned human immunodeficiency virus type 1 library. Vaccine, 20: 1181-1185.
Myers G., Korber B., Foley B., Jeang K.T., Mellors J.W., Wain-Hobson S. (1996). Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics Group, Los Alamos National laboratory, los Alamos, N.Mex.
Ndung’u T., Renjifo B., Essex M. (2001). Construction and analysis of an infectious human immunodeficiency virus type 1 subtype C moleculòar clone. J. Virol., 75: 4964-4972.
Neuvent C., Vigne R., Clements J.E., Sire J. (1993). The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes. Virology, 197: 236-244.
Novelli P., Vella C., Oxford J., Daniels R.S. (2002). Construction and characterization of a full-length HIV-1(92UG001) subtype D infectious molecular clone. AIDS Res. Hum. Retrovir., 18: 85-88.
Novitsky V.A., Montano M.A., McLane M.F., Renjifo B., Vannberg F., Foley B.T., Ndung’u T., Rahman M., Makhema M.J., Marlink R., Essex M. (1999). Molecular cloning and phylo genetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. J. Virol., 73: 4427-4432.
Olmsted R.A., Hirsch V.M., Purcell R.H., Johnson P.R. (1989). Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc. Natl. Acad. Sci. USA. 86: 8088-8092.
Palca J. (1992). Human SIV infections suspect. Science, 257: 606.
Pancino G., Fossati I., Chappey C., Castelot S., Hurtrel B., Moraillon A., Klatzmann D., Sonigo P. (1993). Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology, 192: 659-662.
Parren P.W.H.I., Moore J.P., Burton D.R., Sattentau Q.J. (1999). The neutralization antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS, 13: S137-S162.
Pecoraro M.R., Tomonaga K., Miyazawa T., Kawaguchi Y., Sugita S., Tohya Y., Kai C., Etcheverrigaray M.E., Mikami T. (1996). Genetic diversity of Argentine isolates of feline immunodeficiency virus. J. Gen. Virol., 77: 2031-2035.
Peden K., Emerman M., Montagnier L. (1997). Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL and HIV-1ELI. Virology, 185: 661-672.
Pedersen NC., Ho EW., Brown ML., Yamamoto JK. (1987). Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science, 235: 790-793.
Pedersen N.C. (1993). The feline immunodeficiency virus. In J. A. Levy (ed). The Retroviruses, vol. 2. Plenum Press, New York.
Phillips T.R., Talbott R.L., Lamont C., Muir S., Lovelace K., Elder J.H. (1990). Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol., 64: 4605-4613.
Phillips T.R., Lamont C., Konings D.A., Shacklett B.L., Hamson C.A., Luciw P.A., Elder J.H. (1992). Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol., 66: 5464-5471.
Pistello M., Cammarota G., Nicoletti E., Matteucci D., Curcio M., Del Mauro D., Bendinelli M. (1997). Analysis of the genetic diversity and phylogenetic relantionship of Italian isolates of feline immunodeficiency virus indicates a high prevalence and heterogeneity of subtype B. J. Gen. Virol., 78: 2247-2257.
Pistello M., Moscardini M., Mazzetti P., Bonci F., Zaccaro L., Isola P., Freer G., Specter S., Matteucci D., Bendinelli M. (2002). Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterization. Virology, 298: 84-95.
Poli A., Abramo F., Di Iorio C., Cantile C., Carli M.A., Pollera C., Vago L., Tosoni A., Costanzi G. (1997). Neuropathology in cats experimentally infected with feline immunodeficiency virus: a morphological, immunocytochemical and morphometric study. J. Neurovirol., 3: 361-368.
Pu R., Coleman J., Omori M., Mison M., Huang C., Arai M., Tanabe t., Yamamoto J.K. (2001). Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates. AIDS, 15: 1-13.
Reggeti F. and Bienzle D. (2004). Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, Canada. J. Gen. Virol., 85: 1843-1852.
Richardson J., Pancino G., Merat R., Leste-Lasserre T., Moraillon A., Schneider-Mergener J. et al. (1999). Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J. Virol., 73: 3661-3671.
Riley J., Butler R., Ogilvie D., Finniear R., Jenner D., Powell S., Anand R., Smith J.C., Markham A.F. (1990). A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res., 18: 2887-2890.
Rimmelzwaan G.F., Siebelink K.H., Broos H., Drost G.A., Weijer K., van Herwijnen R., Osterhaus A.D. (1994). Gag- and Env-specific serum antibodies in cats after natural and experimental infection with feline immunodeficiency virus. Vet. Microbiol., 39: 153-165.
Rodriguez M.A., Chen Y., Craigo J.K., Chatterjee R., Ratner D., Tatsumi M., Roy P., Neogi D., Gupta P. (2005). Construction and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin. Virology, 417: 806-810.
Salminen M.O., Ehrenberg P.K., Mascola J.R., Dayhoff D.E., Merling R., Blake B., Louder M., Hegerich S., Polonis V.R., Birx D.L., Robb M.L., McCutchan F.E., Michael N.L. (2000). Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction. Virology, 278: 103-110.
Sewell A.K., Price D.A., Oxenius A., Kelleher A.D., Phillips R.E. (2000). Cytotoxic T lymphocyte response to human immunodeficiency virus: control and escape. Stem Cell., 18: 230-244.
Shimojima M., Miyazawa T., Ikeda Y., McMonagle E.L., Haining H., Akashi H., Takeuchi Y., Hosie M.J., Willett B.J. (2004). Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science, 303: 1192-1195.
Siebelink K.H.J., Chu I.H., Rimmelzwaan G.F., Weijer K., van Herwijnen R., Knell P., Egberink H.F., Bosch M.L., Osterhaus A.D.M.E. (1990). Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Res. Hum., Retroviruses, 6: 1373-1378.
Sodora D.L., Shpaer E.G., Kitchell B.E., Dow S.W., Hoover E.A., Mullins J.I. (1994). Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J. Virol., 68: 2230-2238.
Sparger E.E., Shacklett B.L., Renshaw-Gegg L., Barry P.A., Pedersen N.C., Elder J.H., Luciw P.A. (1992). Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology, 187: 165-177.
Steinman R., Dombrowski J., O’Connor T., Montelaro R.C., Tonelli Q., Lawrence K., Seymour J., Goodness J., Pedersen N.C., Andersen P.R. (1990).
Biochemical and immunological characterization of the major structural proteins of feline immunodeficiency virus. J. Gen. Virol., 71: 701-706.
Stephens E.B., Butfiloski E.J., Monck E. (1992). Analysis of the amino terminal presequence of the feline immunodeficiency virus glycoprotein: effect of deletions on the intracellular transport of gp95. Virology. 190: 569-578.
Talbott R.L., Sparger EE., Lovelace K.M., Fitch W.M., Pedersen N.C., Luciw P.A., Elder J.H. (1989). Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci USA, 86: 5743-5747.
Tebit D.M., Zekeng L., Kaptuè L., Krausslich H.G., Herchenroder O. (2003). Construction and characterization of a full-length infectious molecular clone from a fast replicating, X4-tropic HIV-1 CRF02.AG primary isolate. Virology, 313: 645-652.
Tebit D.M., Zekeng L., Kaptuè L., Gurtler L., Fackler O.T., Keppler O.T., Herchenroder O., Krausslich H.G. (2004). Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives. Virology, 326: 329-339.
Tomonaga K., Norimine J., Shin Y.S., Fukasawa M., Miyazawa T., Adachi A., Toyosaki T., Kawaguchi Y., Kai C., Mikami T. (1992). Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol., 66: 6181-6185.
Tomonaga K., Miyazawa T., Sakuragi J., Mori T., Adachi A., Mikami T. (1993). The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes. J. Virol., 10: 5889-5895.
Tomonaga K., Inoshima Y., Ikeda Y., Mikami T. (1995). Temporal patterns of feline immunodeficiency virus transcripts in peripheral blood cells during the latent stage of infection. J. Gen. Virol., 76: 2193-2204.
Tomonaga K. and Mikami T. (1996). Molecular biology of the feline immunodeficiency virus auxiliary genes. J. Gen. Virol., 77: 1611-1621.
Torten M., Franchini M., Barlough J.E., George J.W., Mozes E., Lutz H., Pedersen N.C. (1991). Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J. Virol., 65: 2225-2230.
Ueland K. and Nesse L.L. (1992). No evidence of vertical transmission of naturally acquired feline immunodeficiency virus infection. Vet. Immunol. Immunopathol., 33: 301-308.
Vahlenkamp T.W., de Ronde A., Schuurman N.N.M.P., van Vliet A.L.W., van Drunen J., Horzinek M.C., Egberink H.F. (1999). Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline immunodeficiency virus. J. Gen. Virol., 80: 2639-2646.
Wichroski M.J., Ichiyama K., Rana T.M. (2005). Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization. J. Biol. Chem.., 280: 8387-8396.
Willett B.J., Picard L., Hosie M.J., Turner J.D., Adema K., Clapham P.R. (1997). Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol., 71: 6407-6415.
Wrin T., Loh T.P., Charron-Vennani J., Schuitemarker H., Nunberg J.H. (1995). Adaption to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol., 69: 39-48.
Yamamoto J.K., Hansen H., Ho E.W., Morishita T.Y., Okuda T., Sawa T.R., Nakamura R.M., Pedersen N.C. (1989). Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 194: 213-220.
Yamamoto J.K., Hohdatsu T., Olmsted R.A., Pu R., Louie H., Zochlinski H.A., Acevedo V., Johnson H.M., Soulds G.A., Gardner M.B. (1993). Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol., 67: 601-605.
